|
|
611例高危型人乳头瘤病毒感染转诊阴道镜患者的病理结果数据分析
|
Abstract:
目的：通过分析高危型人乳头瘤病毒感染转诊阴道镜患者的检查结果，为临床提供依据。方法：选取2019年9月至2020年11月贵阳市妇幼保健院宫颈癌筛查为HR-HPV感染并转诊阴道镜行组织活检的611例女性患者，收集年龄、TCT、HPV及阴道镜下活检病理结果进行统计学分析。结果：HPV16/18阳性患者中，TCT(？)与TCT(+)相比较，宫颈LSIL？、HSIL+占比差异均俱有统计学意义(P < 0.05)；其它16型HR-HPV阳性中，TCT(？)与TCT(+)患者中，宫颈LSIL？、HSIL+占比差异均具有统计学意义(P < 0.05)；HR-HPV16/18型感染患者中宫颈HISL+检出率高于其他16型HR-HPV感染患者，有统计学意义(P < 0.05)。将HR-HPV阳性者按照≤30、31~40、41~50、51~60、>60岁进行分组，各年龄组间HSIL差异无统计学意义(P > 0.05)。各年龄组间宫颈癌占比差异有统计学意义(χ2 = 45.133, P < 0.05)。不同程度细胞学异常中宫颈活检为HSIL+的检出率差异有统计学意义(χ2 = 92.384, P < 0.05)。结论：1) 本中心宫颈HR-HPV阳性并转诊阴道镜患者中，合并TCT阳性转阴道镜者HSIL+病检检出率高；TCT阴性转诊阴道镜者可检出宫颈病变，行HR-HPV、TCT联合阴道镜检查提高宫颈病变检出率，并需长期规范管理该类人群。2) 宫颈癌的发生率随着年龄的增长呈明显上升趋势，60岁以上人群检出率最高，60岁后宫颈高级别病变检出率有降低趋势。故对于适龄女性，注重宫颈癌三级预防的宣教。为降低宫颈病变的漏诊、误诊率及过度诊疗，增加患者精神、心理、经济负担，需根据患者病情增加相关实验室检查。
Objective: To provide clinical evidence by analyzing the examination results of patients with high-risk human papillomavirus infection referred for colposcopy. Methods: 611 female patients who were screened for HR-HPV infection and referred for colposcopic tissue biopsy in Guiyang Maternal and Child Health Care Hospital from September 2019 to November 2020 were selected, and age, TCT, HPV and pathological results of colposcopic biopsy were collected for statistical analysis. Results: In HPV16/18 positive patients, there were significant differences in the proportion of cervical LSIL？ and HSIL+ between TCT(？) and TCT(+) in HPV16/18 positive patients, there were significant differences in the proportion of cervical LSIL？ and HSIL+ between TCT(？) and TCT(+) (P < 0.05). There was a significant difference in the proportion of cervical LSIL？ and HSIL+ between TCT(？) and TCT(+) patients with other 16 types of HR-HPV, and the detection rate of cervical HISL+ in patients with HR-HPV16/18 infection was significantly higher than that in other 16 HR-HPV infection patients (P < 0.05). The HR-HPV positive patients were divided into groups according to ≤30, 31~40, 41~50, 51~60 and >60 years old, and there was no statistically significant difference in HSIL among all age groups (P > 0.05). There was a significant difference in the proportion of cervical cancer among all age groups (χ2 = 45.133, P < 0.05). HSIL and SCC detected by
| [1] | 姜丹凤, 朱孟秀, 赵清娟, 等. 中国女性生殖系统肿瘤发病率和死亡率分析[J]. 现代肿瘤医学, 2023, 31(23): 4426-4431. |
| [2] | Burd, E.M. (2003) Human Papillomavirus and Cervical Cancer. Clinical Microbiology Reviews, 16, 1-17. https://doi.org/10.1128/cmr.16.1.1-17.2003 |
| [3] | 肖琳琳, 孙江川, 常淑芳, 等. 门诊机会筛查患者HPV感染现状分析[J]. 重庆医学, 2016, 45(14): 1945-1947. |
| [4] | 缪文莉. HR-HPV、TCT联合电子阴道镜下宫颈活检在宫颈癌前病变及宫颈癌诊断中的价值分析[J]. 实用妇科内分泌电子杂志, 2021, 8(32): 77-79. |
| [5] | 魏艳杰. HPV联合TCT检测在早期宫颈癌诊断中的价值分析[J]. 中国医疗器械信息, 2021, 27(22): 14-15+92. |
| [6] | 贾小平, 吴婵玉, 周静, 等. TCT与阴道镜在HR-HPV阳性女性子宫颈高级别及以上鳞状上皮内病变诊断中的应用价值[J]. 妇产与遗传(电子版), 2023, 13(1): 25-29. |
| [7] | 沈洁, 高丽丽, 张月, 等. 北京市宫颈癌筛查妇女中高危型HPV感染状况及在宫颈癌前病变中的分布[J]. 中华预防医 学杂志, 2018, 52(5): 493-497. |
| [8] | 谢幸, 孔北华, 段涛. 妇产科学[M]. 第9版. 北京: 人民卫生出版社, 2018: 402-403. |
| [9] | 孙君华, 叶永生, 徐小晶. 中青年宫颈癌患者预后影响因素分析[J]. 医药论坛杂志, 2024, 45(6): 637-640. |
| [10] | 孙宇虹, 朱正英. 液基细胞学检查和高危性人类乳头状瘤病毒DNA检测对宫颈病变的诊断价值[J]. 安徽医药, 2017, 21(1): 109-112. |
| [11] | Zhao, S., Huang, L., Basu, P., Domingo, E.J., Supakarapongkul, W., Ling, W.Y., et al. (2022) Cervical Cancer Burden, Status of Implementation and Challenges of Cervical Cancer Screening in Association of Southeast Asian Nations (ASEAN) Countries. Cancer Letters, 525, 22-32. https://doi.org/10.1016/j.canlet.2021.10.036 |
| [12] | 张莉, 李银河. 我国城乡宫颈癌死亡率趋势分析及预测[J]. 现代肿瘤医学, 2024, 32(5): 927-932. |
| [13] | 田继红. 中老年宫颈癌患者5年生存情况及影响因素[J]. 中国卫生工程学, 2021, 20(5): 779-780. |
| [14] | Xia, L., Zheng, R., Xu, Y., Xu, X., Zhang, S., Zeng, H., et al. (2019) Incidence and Mortality of Primary Bone Cancers in China, 2014. Chinese Journal of Cancer Research, 31, 135-143. https://doi.org/10.21147/j.issn.1000-9604.2019.01.08 |
| [15] | 周静, 玛依努尔·尼亚孜, 周琦, 等. 我国西部地区宫颈癌患者HPV感染现状及影响因素分析[J]. 中国妇产科临床杂志, 2020, 21(1): 13-16. |
| [16] | 许成成. 2063例感染高危人乳头瘤病毒女性转诊阴道镜的临床分析[J]. 现代实用医学, 2024, 36(1): 49-52. |
| [17] | 王化春. 2045例高危型HPV感染转诊阴道镜患者的宫颈病变数据分析[D]: [硕士学位论文]. 苏州: 苏州大学, 2022. |
| [18] | 中国子宫颈癌综合防控路径建设专家共识[J]. 中国预防医学杂志, 2022, 23(10): 721-726. |
| [19] | 段玉坤, 刘桂兰. 宫颈病变与HPV感染的相关性及HPV感染危险因素分析[J]. 当代医药论丛, 2020, 18(12): 20-22. |
| [20] | Xie, S., Pan, S., Zou, S., Zhu, H. and Zhu, X. (2020) Characteristics and Treatments of Patients Aged 65 Years or over with Cervical Cancer. Clinical Interventions in Aging, 15, 841-851. https://doi.org/10.2147/cia.s255305 |
| [21] | Li, K., Yin, R., Wang, D. and Li, Q. (2017) Human Papillomavirus Subtypes Distribution among 2309 Cervical Cancer Patients in West China. Oncotarget, 8, 28502-28509. https://doi.org/10.18632/oncotarget.16093 |
| [22] | 鲍亚玲, 贾维宁, 杨子娇. 高危型HPV感染患者阴道微生态特点及miR-155、miR-222表达水平的相关性分析[J]. 中国病原生物学杂志, 2024, 19(6): 648-652. |
| [23] | Peng, J., Yuan, Y., Shen, F., Wang, Y., Chen, L., Liao, D.J., et al. (2017) Cervical Cancers Manifest a High Rate of Infection by a High-Risk Human Papilloma Virus Subtype but a Very Low Rate of Infection by a Low-Risk Subtype in the Guiyang District of China. Journal of Cancer, 8, 1263-1270. https://doi.org/10.7150/jca.17120 |
| [24] | 董珍珠, 游盛俊, 饶靖红. 4169例绝经后妇女宫颈癌筛查方案分析[J]. 中国医药指南, 2024, 22(14): 131-134. |
| [25] | 李锦花, 梁晓燕, 刘银凤. 阴道镜阴性象限活检结合高危HPV mRNA诊断宫颈癌的价值[J]. 中国计划生育和妇产科, 2024, 16(4): 37-40+46+113. |
| [26] | Bruno, M.T., Bonanno, G., Sgalambro, F., Cavallaro, A. and Boemi, S. (2023) Overexpression of E6/E7 mRNA HPV Is a Prognostic Biomarker for Residual Disease Progression in Women Undergoing LEEP for Cervical Intraepithelial Neoplasia 3. Cancers, 15, 4203-4213. https://doi.org/10.3390/cancers15174203 |
| [27] | Ikenberg, H., Bergeron, C., Schmidt, D., Griesser, H., Alameda, F., Angeloni, C., et al. (2013) Screening for Cervical Cancer Precursors with P16/KI-67 Dual-Stained Cytology: Results of the PALMS Study. JNCI: Journal of the National Cancer Institute, 105, 1550-1557. https://doi.org/10.1093/jnci/djt235 |
| [28] | 白菊萍, 徐星榕, 边芸. P16, P53及Ki67在子宫颈鳞状细胞癌(SCC), 宫颈上皮内瘤变(CIN)及慢性炎症中表达水平及临床意义[J]. 中国妇产科临床杂志, 2022, 23(5): 474-476. |
